Worth reading
62In focus
Scored from 3 of 5 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
525
¥ million (decrease in expected proceeds)Wording
Conditional
How definitive the wording is.Details of issuance or disposal
Change in the use of funds raised in connection with the issuance of stock acquisition rights with provisions for exercise price adjustments (Series 5 to Series 7)
Amount of funds to be raised
Total use of funds after the change: ¥1,579 million. Expected proceeds decreased by ¥525 million as a result of the acquisition and cancellation of the Series 8 Stock Acquisition Rights
Specific use of funds
Perovskite solar cell business: capital expendituresAmount ¥615 million / Scheduled timing of expenditures April 2025 to December 2027
Perovskite solar cell business: working capitalAmount ¥152 million / Scheduled timing of expenditures July 2025 to December 2026
Robotics business: R&D fundingAmount ¥161 million / Scheduled timing of expenditures September 2025 to December 2026
E-commerce business: working capitalAmount ¥100 million / Scheduled timing of expenditures July 2025 to December 2027
AI high-speed camera business: capital expenditures and working capitalAmount ¥98 million / Scheduled timing of expenditures July 2025 to December 2027
Electronic dimming business: capital expenditures and working capitalAmount ¥99 million / Scheduled timing of expenditures July 2025 to December 2027
Solar panel recycling business: establishment of a joint ventureAmount ¥100 million / Scheduled timing of expenditures July 2025 to December 2026
Perovskite solar cell business: capital expendituresAmount ¥252 million / Scheduled timing of expenditures January 2027 to December 2027
Terms of the stock acquisition rights
Exercise price
Series 5: ¥225; Series 6: ¥275; Series 7: ¥325. Whether adjustment provisions apply and the floor price are Not disclosed
Number of Stock Acquisition Rights
All remaining Series 8 Stock Acquisition Rights are scheduled to be acquired and cancelled on 15 July 2026. The number of Series 5 to Series 7 Stock Acquisition Rights and the number outstanding and unexercised are Not disclosed
Reason for acquisition without consideration
All Series 8 Stock Acquisition Rights remaining on 15 July 2026 (scheduled) will be acquired and immediately cancelled after acquisition
Most recent equity financing
Timing 1 April 2026 / Type Issuance of new shares / Amount ¥82 million, Timing Not disclosed / Type Issuance of the Ninth Series of Stock Acquisition Rights / Amount ¥565 million (of which ¥119 million had already been exercised as of today), Timing 1 July 2026 / Type Issuance of new shares / Amount ¥395 million
Impact on Business Performance
The impact of this change in the use of funds on the results of the Company group is immaterial
| Item | Details |
|---|---|
| Type of issuance or disposal | Change in the use of funds raised in connection with the issuance of stock acquisition rights with provisions for exercise price adjustments (Series 5 to Series 7) |
| Amount of funds to be raised | Total use of funds after the change: ¥1,579 million. Expected proceeds decreased by ¥525 million as a result of the acquisition and cancellation of the Series 8 Stock Acquisition Rights |
| Specific use of funds | Details Perovskite solar cell business: capital expenditures / Amount ¥615 million / Scheduled timing of expenditures April 2025 to December 2027, Details Perovskite solar cell business: working capital / Amount ¥152 million / Scheduled timing of expenditures July 2025 to December 2026, Details Robotics business: R&D funding / Amount ¥161 million / Scheduled timing of expenditures September 2025 to December 2026, Details E-commerce business: working capital / Amount ¥100 million / Scheduled timing of expenditures July 2025 to December 2027, Details AI high-speed camera business: capital expenditures and working capital / Amount ¥98 million / Scheduled timing of expenditures July 2025 to December 2027, Details Electronic dimming business: capital expenditures and working capital / Amount ¥99 million / Scheduled timing of expenditures July 2025 to December 2027, Details Solar panel recycling business: establishment of a joint venture / Amount ¥100 million / Scheduled timing of expenditures July 2025 to December 2026, Details Perovskite solar cell business: capital expenditures / Amount ¥252 million / Scheduled timing of expenditures January 2027 to December 2027 |
| Exercise price | Series 5: ¥225; Series 6: ¥275; Series 7: ¥325. Whether adjustment provisions apply and the floor price are Not disclosed |
| Number of Stock Acquisition Rights | All remaining Series 8 Stock Acquisition Rights are scheduled to be acquired and cancelled on 15 July 2026. The number of Series 5 to Series 7 Stock Acquisition Rights and the number outstanding and unexercised are Not disclosed |
| Reason for acquisition without consideration | All Series 8 Stock Acquisition Rights remaining on 15 July 2026 (scheduled) will be acquired and immediately cancelled after acquisition |
| Most recent equity financing | Timing 1 April 2026 / Type Issuance of new shares / Amount ¥82 million, Timing Not disclosed / Type Issuance of the Ninth Series of Stock Acquisition Rights / Amount ¥565 million (of which ¥119 million had already been exercised as of today), Timing 1 July 2026 / Type Issuance of new shares / Amount ¥395 million |
| Impact on Business Performance | The impact of this change in the use of funds on the results of the Company group is immaterial |
Items this document does not state (20)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueEstimated issuance expensesPayment dateIntended allotteeIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Because the ¥525 million expected to be raised will no longer be available as a result of the acquisition and cancellation of the Series 8 Stock Acquisition Rights. The Company explained that it will respond by reducing working capital and R&D funding for the robotics business, taking into account the originally assumed priorities among its businesses, the need for R&D in the robotics business, and the status of securing working capital for toilet-cleaning robots.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.